Evolt
PrivateLast Round
VC Round
Sep 26, 2024
Company Overview
Evolt operates in Healthcare & Life Sciences and is based in Australia. Its latest recorded funding round was a VC Round in September 2024.
Evolt is a health technology company that operates a wellness platform intended to provide users with knowledge of their body composition.
Sector
Healthcare & Life Sciences
Verticals
Sports & Fitness, Medical Devices, Healthcare Analytics, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evolt Comparables
Compare Evolt with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Visbody | 83% | |
| Styku | 82% | |
| InBody Co.,Ltd | 82% |
For institutional investors. Book with your work email.
Evolt Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 26, 2024 | ||||
| VC Round | Oct 12, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evolt Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Regal Funds Management | VC Round |
| Bell Potter Securities | VC Round |
| Washington H. Soul Pattinson and Company | VC Round |
| Smarter Capital | VC Round |
| Perennial Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 18, 2025
Grew 16% QoQ, from 57 to 66 employees.
- Sep 26, 2024
$14M raised from Perennial Partners and others.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 14, 2026
On Aug 14th '26, Evolt Health appoints Nick Trosko as Chief Revenue Officer and its first executive leader based in North America, supporting its next phase of global growth.
- hiresAug 14, 2026
On Aug 14th '26, Evolt Health welcomes Nick Trosko as CRO to lead its Sales, Marketing, Customer Success, and Distribution teams as it enters its next phase of growth.
For institutional investors. Book with your work email.
Evolt Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evolt's valuation, stock price, and market status.
Is Evolt a public or private company?
Evolt is a private company.
What is the current stock price of Evolt?
Evolt is a private company, so its shares have no public market price. Caplight tracks Evolt's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evolt worth (valuation)?
Valuation information for Evolt is not publicly available.
Can I buy Evolt stock?
Evolt shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evolt's last funding round?
Evolt's most recent funding round was VC Round on September 26, 2024.
Who are the main investors in Evolt?
Key investors in Evolt include Bell Potter Securities.
Will Evolt IPO soon?
No public IPO plans have been announced for Evolt.
How can I track Evolt secondary market activity?
Caplight tracks bids, offers, and trades in Evolt's shares on secondary markets.